Rallybio Corporation
RLYB
$16.99
$0.030.18%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 209.36% | 83.78% | 84.46% | 78.84% | 43.62% |
| Total Depreciation and Amortization | -62.93% | -45.97% | -29.77% | -13.14% | -18.31% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -334.89% | -313.25% | -294.14% | -269.48% | -9.67% |
| Change in Net Operating Assets | 109.69% | 69.49% | -1,524.81% | -183.44% | -184.82% |
| Cash from Operations | 163.61% | 37.35% | 39.51% | 31.47% | 22.23% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 62.75% | 57.65% | 41.13% | -19.65% | 5.77% |
| Cash from Investing | 62.75% | 57.65% | 41.13% | -19.63% | 5.81% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 400.00% | -99.65% | -99.71% | -99.49% | -99.49% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 100.00% | 95.74% |
| Cash from Financing | 723.53% | -99.63% | -99.69% | -99.47% | -99.68% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,254.22% | 686.47% | 264.96% | 10.39% | 54.52% |